Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 5/20 | 0.59 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
| ▸ | CA5A | P35218 | 2/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | SELL | P14151 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | SELP | P16109 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1951073 | 0.94 | TPMT (0.59) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL9988254 | 0.85 | CA12 (0.68) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL4757914 | 0.83 | TPMT (0.70) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL29528960 | 0.83 | TPMT (0.48) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL200827 | 0.83 | TPMT (0.48) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL10799482 | 0.83 | TPMT (0.48) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL12837657 | 0.83 | TPMT (0.48) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL7947897 | 0.83 | DHODH (0.55) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL1947967 | 0.83 | HCAR1 (0.59) | TPMTCA12CA1CA2CA7 | |
| SCHEMBL16925558 | 0.83 | TPMT (0.70) | TPMTCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116440315-A | Multi-mode developed gelatin sponge microsphere and preparation method thereof | 海南百迈科医疗科技股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-115487342-A | Self-developing absorbable embolism microsphere and preparation method thereof | 海南百迈科医疗科技股份有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-113995884-A | Liquid embolic agent and preparation method thereof | 苏州浩微生物医疗科技有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-106822983-B | Developable embolism microsphere for treating tumor diseases by minimally invasive intervention therapy and preparation method thereof | 苏州恒瑞迦俐生生物医药科技有限公司 | 2020-09-15 | — | — | CN | claimed |
| US-9433501-B2 | Inflation media for implants | DIRECT FLOW MEDICAL, INC. (US) | 2016-09-06 | — | — | US | claimed |
| EP-2571561-A2 | INFLATION MEDIA FOR IMPLANTS | Direct Flow Medical, Inc. (US) | 2013-03-27 | — | — | EP | claimed |
| US-20120022629-A1 | INFLATION MEDIA FOR IMPLANTS | DIRECT FLOW MEDICAL, INC. (US) | 2012-01-26 | — | — | US | claimed |
| WO-2011146759-A2 | INFLATION MEDIA FOR IMPLANTS | DIRECT FLOW MEDICAL, INC. (US) | 2011-11-24 | — | — | WO | claimed |
| US-20090203877-A1 | X-RAY-DENSE CONJUGATE | EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINKUM | 2009-08-13 | — | — | US | claimed |
| EP-2046392-A2 | RADIODENSE CONJUGATE | Eberhard-Karls-Universität Tübingen Universitätsklinikum (DE) | 2009-04-15 | — | — | EP | claimed |
| WO-2008012102-A2 | RADIODENSE CONJUGATE | EBERHARD-KARLS-UNIVERSITAET TUEBINGEN UNIVERSITAETSKLINIKUM (DE) | 2008-01-31 | — | — | WO | claimed |
| CN-1284773-C | Ortho-pyridinequinone derivative, composite containing said derivative, its preparation method and application | BAIRUI GLOBAL CO LTD (VG) | 2006-11-15 | — | — | CN | claimed |
| CN-1477099-A | O-pyridinoquinone derivative, composition containing the same, preparation method and use of the same | 百瑞全球有限公司 | 2004-02-25 | — | — | CN | claimed |
| CN-122029155-A | Heterocyclic compound and harmful arthropod control composition containing same | 住友化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-12610949-B2 | Heteroaryl-triazole compounds as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2026-04-28 | — | — | US | disclosed |
| US-4563465-A | ANTISEROTONINE AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1986-01-07 | — | — | US | disclosed |
| US-4486441-A | PROPHYLAXIS | MERRELL TORAUDE ET COMPAGNIE (FR) | 1984-12-04 | — | — | US | disclosed |
| EP-0111608-A1 | Pseudotropyl halogeno-benzoates and their use in migraine treatment | MERRELL TORAUDE ET COMPAGNIE (FR) | 1984-06-27 | — | — | EP | disclosed |
| EP-0067770-A2 | Treatment of migraine with tropyl benzoate derivatives | MERRELL DOW FRANCE ET CIE (FR) | 1982-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12610949-B2 | Heteroaryl-triazole compounds as pesticides | CTRL, PTMS, DDT | TPMT 1299/4885CA12 4183/4885CA1 3529/4885 |
| US-20090203877-A1 | X-RAY-DENSE CONJUGATE | FCGR3B, KLK3, XPA | TPMT 2515/4885CA12 140/4885CA1 1247/4885 |
| US-20260115330-A1 | RADIOPAQUE MULTI-ARM POLYMERS FOR MEDICAL APPLICATIONS | KLK3, BRDT, BPHL | TPMT 4080/4885CA12 233/4885CA1 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.